中文
English
한국어
日本語
Español
Français
Русский
| カタログ番号 | MY257117 |
|---|---|
| 説明 |
Anti-Mouse CD20/MS4A1 Antibody (18B12), FITC [18B12] (MY257117) is a mouse monoclonal antibody detecting MS4A1 in FCM, IF, WB. Suitable for Mouse.
Highlights
|
| 種反応性 | Mouse |
| アプリケーション | FCM, IF, WB |
| 宿主種 | Mouse |
| アイソタイプ | IgG2a, kappa |
| クローンID | 18B12 |
| 抱合 | FITC |
| クローン性 | Monoclonal |
| ターゲット | B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20 |
| エンドトキシンレベル | Please contact with the lab for this information. |
| アクセッション番号 | P19437 |
| 形態 | Liquid |
| 保存バッファー | 0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300. データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
| 安定性と保存 | Store at 4°C for 12 months. Protect from light. Do not freeze. |
| 背景 | B-lymphocyte antigen CD20 (MS4A1) is a ~31 kDa protein. B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes. Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR. CD20 is the therapeutic target of rituximab (MabThera) and obinutuzumab (Gazyva). |
| 注意事項 | For flow cytometric staining, the suggested use of this reagent is 0.5 µg per million cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application. For research use only. |
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
